Polo-like kinase 1 promotes pulmonary hypertension

Polo样激酶1促进肺动脉高压

阅读:3
作者:Rongrong Chen # ,Hongfei Wang # ,Cuiting Zheng # ,Xiyu Zhang ,Li Li ,Shengwei Wang ,Hongyu Chen ,Jing Duan ,Xian Zhou ,Haiyong Peng ,Jing Guo ,Anchen Zhang ,Feifei Li ,Wang Wang ,Yu Zhang ,Jun Wang ,Chen Wang ,Yan Meng ,Xinling Du ,Hongbing Zhang

Abstract

Background: Pulmonary hypertension (PH) is a lethal vascular disease with limited therapeutic options. The mechanistic connections between alveolar hypoxia and PH are not well understood. The aim of this study was to investigate the role of mitotic regulator Polo-like kinase 1 (PLK1) in PH development. Methods: Mouse lungs along with human pulmonary arterial smooth muscle cells and endothelial cells were used to investigate the effects of hypoxia on PLK1. Hypoxia- or Sugen5416/hypoxia was applied to induce PH in mice. Plk1 heterozygous knockout mice and PLK1 inhibitors (BI 2536 and BI 6727)-treated mice were checked for the significance of PLK1 in the development of PH. Results: Hypoxia stimulated PLK1 expression through induction of HIF1α and RELA. Mice with heterozygous deletion of Plk1 were partially resistant to hypoxia-induced PH. PLK1 inhibitors ameliorated PH in mice. Conclusions: Augmented PLK1 is essential for the development of PH and is a druggable target for PH. Keywords: HIF1α; Hypoxia; Polo-like kinase 1; Pulmonary hypertension; RELA/p65.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。